Hormone Therapy Exclusion Leaves Millions Feeling Left Out

Millions of women face significant frustration as they are unable to access hormone therapy (HT), a treatment widely lauded for alleviating menopause symptoms. Conditions including various cancers, cardiovascular concerns, and clotting disorders exclude these individuals from treatments like estrogen or progesterone pills and patches.

Women like Cybele Maylone and Rebecca Hastings express feeling isolated, as widespread positive messaging about HT makes their own symptom management feel like a struggle. Ms. Maylone, a breast cancer survivor, feels cut off from the relief her peers describe, while Ms. Hastings navigates hot flashes and night sweats due to a genetic predisposition to blood clots.

While alternative treatments exist, a knowledge gap among providers and patients means these options are often overlooked. Newly approved non-hormonal drugs, such as fezolinetant (Veozah) and elinzanetant (Lynkuet), target hot flashes neurologically. Other alternatives include antidepressants, cognitive behavioral therapy, and lifestyle adjustments, though they may not fully eliminate symptoms.

Experts like Dr. Rajita Patil and Dr. Stephanie Faubion highlight the need for greater awareness of these diverse treatment options. They emphasize that while HT has specific approved uses, its promotion often overreaches, leaving those ineligible feeling deprived of a 'golden ticket' to symptom relief. However, these women have not missed out on all potential relief.